Skip to main content
. 2010 Jul 25;4(3):634–640. doi: 10.1007/s12072-010-9194-2

Table 3.

Characteristics of the studied patients with non-cholestatic CLD by 25-hydroxy vitamin D status (n = 90)

Variables Vitamin D (nmol/l)
<25 25–49 50–79 ≥80
n (%) 23 (25.6) 23 (25.6) 15 (16.7) 29 (32.2)
Vitamin D (n mol/l)* 17.67 ± 3.48 38.09 ± 7.76 64.75 ± 10.27 103.78 ± 16.90
PTH (pmol/dl) 18.97 ± 9.81 21.04 ± 9.18 24.70 ± 14.99 25.41 ± 16.28
Ca (mg/dl) 8.99 ± 0.39 8.95 ± 0.77 8.85 ± 0.57 8.94 ± 0.52
P (mg/dl) 2.98 ± 0.61 3.08 ± 0.58 3.15 ± 0.65 3.13 ± 0.55
Cirrhotic patients, n (%)* 23 (45.1) 16 (31.4) 5 (9.8) 7 (13.6)
Child–Pugh classification (n, %)a,*
 Child A 5 (22.7) 5 (22.7) 5 (22.7) 7 (31.8)
 Child B 6 (60.0) 4 (40.0) 0 (0) 0 (0)
 Child C 12 (63.2) 7 (36.8) 0 (0) 0 (0)
MELD scorea,* 17.70 ± 5.57 13.62 ± 3.34 10.71 ± 2.77 10.20 ± 2.43
Albumin (g/dl)* 2.87 ± 0.47 3.43 ± 0.75 4.13 ± 0.78 4.21 ± 0.48
INR* 1.72 ± 0.47 1.39 ± 0.27 1.13 ± 0.12 1.15 ± 0.18
PLT count* 74,130 ± 32,169 137,652 ± 94,800 164,400 ± 63,359 188,551 ± 79,999
Hb (g/l)* 10.04 ± 1.88 11.87 ± 2.83 13.32 ± 2.17 13.80 ± 1.62
Bil (mg/dl)* 4.40 ± 4.01 1.89 ± 1.06 1.46 ± 0.82 1.26 ± 1.01
AST (U/l) 89.39 ± 60.00 89.43 ± 75.24 76.14 ± 45.11 64.13 ± 61.03
ALT (U/l) 55.83 ± 34.44 69.26 ± 59.81 77.87 ± 49.04 84.17 ± 73.35
ALP (U/l) 269.83 ± 89.22 278.78 ± 133.75 246.87 ± 89.97 269.24 ± 112.77
Cr (mg/dl) 0.96 ± 0.21 0.95 ± 0.18 0.93 ± 0.12 0.97 ± 0.17
Urea (mg/dl) 35.17 ± 9.60 29.83 ± 6.97 29.80 ± 6.71 31.28 ± 7.94

Data are expressed as mean ± SD, unless otherwise is stated

CLD chronic liver disease, MELD Model for End-Stage Liver Disease, PTH parathyroid hormone, Ca calcium, P phosphate, INR international normalized ratio, PLT platelet count, Hb hemoglobin, Bil bilirubin, AST aspartate transaminases, ALT alanine transaminases, ALP alkaline phosphatase, Cr creatinine

aCalculated in cirrhotic patients only

* P < 0.001; P values are derived from chi square analysis or analysis of variances (ANOVA) among the four groups